Impact of Polypharmacy on the Rehabilitation Outcome of Japanese Stroke Patients in the Convalescent Rehabilitation Ward

Background. A risk factor associated with stroke onset is chronic kidney disease (CKD). To prevent stroke reoccurrence, it is necessary to strictly manage blood pressure, lipids, and plasma glucose. Therefore, some cases are forced to polypharmacy, elderly patients in particular. Polypharmacy often...

Full description

Saved in:
Bibliographic Details
Main Authors: Eiji Kose, Riku Maruyama, Susumu Okazoe, Hiroyuki Hayashi
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Journal of Aging Research
Online Access:http://dx.doi.org/10.1155/2016/7957825
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832550059593433088
author Eiji Kose
Riku Maruyama
Susumu Okazoe
Hiroyuki Hayashi
author_facet Eiji Kose
Riku Maruyama
Susumu Okazoe
Hiroyuki Hayashi
author_sort Eiji Kose
collection DOAJ
description Background. A risk factor associated with stroke onset is chronic kidney disease (CKD). To prevent stroke reoccurrence, it is necessary to strictly manage blood pressure, lipids, and plasma glucose. Therefore, some cases are forced to polypharmacy, elderly patients in particular. Polypharmacy often leads to adverse drug reactions and has the potential to negatively affect the rehabilitation of stroke patients. The aim of the present study was to investigate the effects of polypharmacy using a functional independence measure (FIM). Methods. A total of 144 stroke patients with CKD were included in the present analysis. We divided stroke patients into those taking six or more drugs (polypharmacy group) and those taking less than six drugs (nonpolypharmacy group) upon admission. Patient background features, laboratory data, and FIM scores were compared. Results. FIM-Motor (FIM-M) efficiency, age, and diabetes mellitus were positively associated with polypharmacy. FIM-M efficiency in the polypharmacy group was significantly lower than in the nonpolypharmacy group. Conclusion. Polypharmacy interferes with the effect of rehabilitation in stroke patients with CKD. Pharmacists and doctors should make efforts to optimize medications to be able to respond to the outcome of each patient.
format Article
id doaj-art-42a55e6de3574408bf78eef931f6d1a1
institution Kabale University
issn 2090-2204
2090-2212
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Journal of Aging Research
spelling doaj-art-42a55e6de3574408bf78eef931f6d1a12025-02-03T06:07:45ZengWileyJournal of Aging Research2090-22042090-22122016-01-01201610.1155/2016/79578257957825Impact of Polypharmacy on the Rehabilitation Outcome of Japanese Stroke Patients in the Convalescent Rehabilitation WardEiji Kose0Riku Maruyama1Susumu Okazoe2Hiroyuki Hayashi3Department of Pharmacotherapy, School of Pharmacy, Nihon University, Chiba, JapanDepartment of Pharmacotherapy, School of Pharmacy, Nihon University, Chiba, JapanDepartment of Pharmacy, Sagami Rehabilitation Hospital, Kanagawa, JapanDepartment of Pharmacotherapy, School of Pharmacy, Nihon University, Chiba, JapanBackground. A risk factor associated with stroke onset is chronic kidney disease (CKD). To prevent stroke reoccurrence, it is necessary to strictly manage blood pressure, lipids, and plasma glucose. Therefore, some cases are forced to polypharmacy, elderly patients in particular. Polypharmacy often leads to adverse drug reactions and has the potential to negatively affect the rehabilitation of stroke patients. The aim of the present study was to investigate the effects of polypharmacy using a functional independence measure (FIM). Methods. A total of 144 stroke patients with CKD were included in the present analysis. We divided stroke patients into those taking six or more drugs (polypharmacy group) and those taking less than six drugs (nonpolypharmacy group) upon admission. Patient background features, laboratory data, and FIM scores were compared. Results. FIM-Motor (FIM-M) efficiency, age, and diabetes mellitus were positively associated with polypharmacy. FIM-M efficiency in the polypharmacy group was significantly lower than in the nonpolypharmacy group. Conclusion. Polypharmacy interferes with the effect of rehabilitation in stroke patients with CKD. Pharmacists and doctors should make efforts to optimize medications to be able to respond to the outcome of each patient.http://dx.doi.org/10.1155/2016/7957825
spellingShingle Eiji Kose
Riku Maruyama
Susumu Okazoe
Hiroyuki Hayashi
Impact of Polypharmacy on the Rehabilitation Outcome of Japanese Stroke Patients in the Convalescent Rehabilitation Ward
Journal of Aging Research
title Impact of Polypharmacy on the Rehabilitation Outcome of Japanese Stroke Patients in the Convalescent Rehabilitation Ward
title_full Impact of Polypharmacy on the Rehabilitation Outcome of Japanese Stroke Patients in the Convalescent Rehabilitation Ward
title_fullStr Impact of Polypharmacy on the Rehabilitation Outcome of Japanese Stroke Patients in the Convalescent Rehabilitation Ward
title_full_unstemmed Impact of Polypharmacy on the Rehabilitation Outcome of Japanese Stroke Patients in the Convalescent Rehabilitation Ward
title_short Impact of Polypharmacy on the Rehabilitation Outcome of Japanese Stroke Patients in the Convalescent Rehabilitation Ward
title_sort impact of polypharmacy on the rehabilitation outcome of japanese stroke patients in the convalescent rehabilitation ward
url http://dx.doi.org/10.1155/2016/7957825
work_keys_str_mv AT eijikose impactofpolypharmacyontherehabilitationoutcomeofjapanesestrokepatientsintheconvalescentrehabilitationward
AT rikumaruyama impactofpolypharmacyontherehabilitationoutcomeofjapanesestrokepatientsintheconvalescentrehabilitationward
AT susumuokazoe impactofpolypharmacyontherehabilitationoutcomeofjapanesestrokepatientsintheconvalescentrehabilitationward
AT hiroyukihayashi impactofpolypharmacyontherehabilitationoutcomeofjapanesestrokepatientsintheconvalescentrehabilitationward